AVAI

Atlas Venture Associates IX Portfolio holdings

AUM $11.8M
This Quarter Return
+77.83%
1 Year Return
-58.35%
3 Year Return
-89.8%
5 Year Return
-87.69%
10 Year Return
AUM
$631M
AUM Growth
+$631M
Cap. Flow
+$423M
Cap. Flow %
66.96%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
Reduced
2
Closed

Top Buys

1
SKLZ icon
Skillz
SKLZ
$466M

Sector Composition

1 Communication Services 74.99%
2 Healthcare 25.01%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SKLZ icon
1
Skillz
SKLZ
$135M
$466M 73.8% +23,284,403 New +$466M
NTLA icon
2
Intellia Therapeutics
NTLA
$1.22B
$87.9M 13.93% 1,615,321
SURF
3
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$27.2M 4.31% 2,945,453 -1,700,000 -37% -$15.7M
SPRO icon
4
Spero Therapeutics
SPRO
$116M
$26.7M 4.23% 1,376,968
COGT icon
5
Cogent Biosciences
COGT
$1.69B
$10.3M 1.63% 916,196 -2,445,339 -73% -$27.5M
SNAP icon
6
Snap
SNAP
$12.1B
$7.52M 1.19% 150,160
SYBX icon
7
Synlogic
SYBX
$17M
$5.73M 0.91% 2,651,963